Author Archives: ove072

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 7 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

The covid-19 epidemic has changed our way of working. How is this affecting female versus male researchers?

Early analyses discussed in a recent article in Nature (10.1038/d41586-020-01294-9) suggest that female academics are posting fewer preprints and starting fewer research projects than their male peers.

COVID-19 is changing the way research is done. World-wide lockdowns mean that, overnight, many households worldwide have become an intersection of work, school, and home life. The new mechanisms of accelerated peer review, the increased quantity and speed of available data, and the distribution of funding across sectors are changing the equilibria of the academic world. We therefore need to pay attention to the effects this has on disparities. What happens when a couple is at home? Is it exacerbating gender inequality? In a commentary in Nature (doi: 10.1038/d41586-020-01135-9) very early during the pandemic, Alessandra Minello suggested it is disproportionately affecting the productivity of female academics, because they often do more caregiving than men.

Megan Frederickson, an ecologist at the University of Toronto being COVID-19-quarantined herself, looked at preprint servers to investigate whether women were posting fewer studies than they were before lockdowns began (https://github.com/drfreder/pandemic-pub-bias/blob/master/README.md). Peer review takes time, it is still too soon to see COVID-19’s effects on the numbers of journal articles published by female versus male academics. However, a growing number of academics make their submitted or in-progress manuscripts available on preprint servers, meaning it might be possible to measure the pandemic’s effect on preprint submissions in real time. She looked at arXiv (physical sciences), and bioRxiv (life sciences) to determine the gender of studies posted between March 15 and April 15 in 2019 and in 2020. The number of women who authored preprints at arXiv increased by 2.7% from 2019 to 2020 — but the number of male authors grew by 6.4% over the same period. The numbers for bioRxiv were 24.2% vs. 26%. A similar trend was found in a separate study including nine popular preprint servers (https://www.natureindex.com/news-blog/decline-women-scientist-research-publishing-production-coronavirus-pandemic). Thus, women’s publishing rate has fallen relative to men’s amid the pandemic.

In another study by the information scientist Cassidy Sugimoto at Indiana University Bloomington on three registered-report repositories including ClinicalTrial.gov, there was a decrease in the proportion of submissions by female principal investigators from March and April of 2019 to the same months in 2020, when lockdowns started. Hence, women are registering a smaller proportion of new research projects than before the pandemic.

What are the likely causes for this effect? Increased household labor and childcare responsibility are probably the major reasons. Also, women more often take care of ailing relatives. The sudden shift to online teaching might mean more work for women as they in average probably have more teaching commitments than men, while the shutdown of the universities might free more time for men to write papers as they more often have non-research commitments.

What can be done to mitigate this effect? Our scientific environment requires the participation of all members of the population; a crisis requires that we draw from the intellect of the full population. As the effects and the pandemic are likely to linger, we must consider how our evaluation systems and resource allocation mechanisms take into account the inequities in labor distribution for women. We need to create infrastructures to allow for all populations to participate, and to acknowledge systematic differences in their ability to do so.

Enjoy your week-end!

PhD defense – Thomas Aga Legøy

Thomas Aga Legøy will defend his PhD thesis on Tuesday 26th May 2020

Trial lecture: Tuesday 26th May at 10:15
Topic: «Pathogenesis of type 1 diabetes»                                                                                             Place: https://tinyurl.com/ThomasLegoys

Public defense: Tuesday 26th May at 12:15                                                                                            Title of dissertation: «Investigating cell fate decisions in the pancreatic islet»                        Place: https://tinyurl.com/ThomasLegoys

1st opponent: Professor Valerie Schwitzgebel, University of Geneva

2nd opponent: PhD Marijana Licina, University of Geneva

3rd member of the committee: Professor Thomas Arnesen, Universitetet i Bergen

The defense will be led by professor Gunnar Mellgren

PhD defense – Hildegunn Høberg Vetti

Hildegunn Høberg Vetti will defend her PhD thesis on Friday 29th May 2020

Trial lecture: Friday 29th May 2020 at 09.15
Topic: “Hvordan kunnskap om arvelighet ved kreft kan endre situasjonen for pasienten, familien og samfunnet”                                                                                                                        Place: https://tinyurl.com/HildegunnVetti

Public defense: Friday 29th May 2020 at 11.15                                                                                  Title of dissertation:«New procedures for genetic testing and counselling of patients with breast or ovarian cancer»                                                                                                                    Place: https://tinyurl.com/HildegunnVetti

1st opponent: Ph.d. Marie Stenmark Askmalm Skånes, Universitetssjukhus, Sverige

2nd opponent: Dr. scient. Grethe S. Foss, Helsedirektoratet

3rd member of the committe: Professor emeritus Ole-Erik Iversen, Universitetet i Bergen

The defense will be led by professor Line Bjørge

PhD-defense – Karl Erik Müller

Karl Erik Müller will defend his PhD thesis on Friday 29th May 2020

Trial lecture: Friday 29th May 2020 at 10.00
Topic: «Vaccine development challenges and implementation of control strategies for elimination of Leishmaniasis in endemic areas»                                                                                Place: https://tinyurl.com/KarlErikMuller

Public defense: Friday 29th May 2020 at 12.00
Title of dissertation: «Characterisation of Leishmania amino acid permease 3 (AAP3) coding sequences and flanking regions as a target for detection and diagnosis of the leishmaniases»      Place: https://tinyurl.com/KarlErikMuller

1st opponent: Professor Anja Tatiana Ramstedt Jensen, University of Copenhagen, Danmark

2nd opponent: PhD Alvaro Acosta Serrano, Liverpool School of tropical Medicine, Storbritannia

3rd member of the committee: Professor Emerita Birgitta Åsjø, Universitetet i Bergen

The defense will be led by professor Silke Appel

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 12 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

This week’s leader

While both our work and personal lives have had to make major adaptions with COVID-19, it has also resulted in unprecedented innovation. Both directly and indirectly COVID-19 has changed all aspects of our lives, from the way we communicate, interact and socialise to our impact upon the planet. As a result of these changes, technology has had to advance, opening up novel solutions and more importantly perhaps, new opportunities. Ironically, and despite our current focus on social distancing, we have learned to come together to accelerate development e.g. upscaling of a new diagnostic tests at NTNU in one month or new hospitals built in a week in China. With the opening of the new incubator already this autumn, and NFR application deadlines just around the corner – there has never been a better time to jump on the wave of innovation.

Finally, the latest memo from Dean Per Bakke suggests that we are now moving in the right direction towards resuming normal lab activities. In order to reintegrate into our normal working lives it is critical that everyone take the “e-learning-course-protective-measures”. So I guess this 17th of May we have more reason than most years to celebrate. Gratulerer med Dagen!

Evaluation of the handling of the corona virus at UiB

As the university is about to open up after this (first) wave of infection with the coronavirus, it is necessary to do an evaluation of what worked well and what worked not so well during the period UiB was closed. The intention is that we are best equipped for any next wave that FHI has suggested may come this fall.

Likewise, it is important to make an assessment of what more permanent changes we can make even if there is no new wave.

We therefore ask for your feedback on how UIB in your opinion has handled the corona situation in the spring of 2020. It is up to you to comment on the fields you want and feel are relevant for you.

We appreciate you taking the time to answer. Deadline: Wednesday 20th May.

Best regards Pål and the leader group at K2.

 

https://skjemaker.app.uib.no/edit_form.php?id=8445565

Faculty Day 2020 – Award Winners

Because of the pandemic the award ceremony of the Faculty Day 2020 is moved to October 21. Until then – here are the award winners. Congratulations to all!

Falch-prisvinnerne, fra venstre: Marte-Helene Bjørk, Henriette Aksnes og Nils Erik Gilhus. Foto/ill.: Silje Alvestad / Privat / Anne Sidsel Herdlevær

Read more about the Faculty of Medicine awards on our Norwegian website.

Invitation to Research Infrastructure Network Meeting

Dear Colleagues,

We are pleased to invite you to our first digital gathering for the informal Research Infrastructure Network at the University of Bergen.

The network is initiated by a core group of three persons at different faculties (Hiwa Målen/SVFA, Susanna Pakkasmaa/MATNAT & Jorunn Viken/PSYKF), to share experiences, information, best practices and the like, and the potential members will be people working hands-on with research infrastructures.

Please see the agenda for our first digital gathering, that will take place on Tuesday 19 May, between 13:00-14:30.

Continue reading

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 12 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

The corona virus epidemics – a new phase

Up till now, the government has had a strategy to knock down the corona virus. The spread of the infection is now under control, and yesterday the government announced that they are now switching to a control strategy. The goal is still the same as before, that our health service should have the capacity to help everyone who needs it, those with coronary illness and those with other illnesses. This means that businesses and activities must still take infection control measures when they open up.

In recent weeks, K2 has opened something up – from only allowing exceptions for critical functions to exceptions essential for those completing a degree in 2020 or to generate preliminary data for research applications or particularly costly or critical experiments. At the time of writing, we do not know how much of our activity K2 can open in the next few weeks. The government proposes that distance education should continue to be the norm after May 11, and those in need of collective travel to work should still have a home office. Presently, we do not know whether there will be new reliefs for the laboratories. When we have received new guidance from the Faculty, we will announce the new guidelines through the research group leaders.

Of course, there is great eagerness to get back to normal life at K2. I’m very happy about that. But it is important to remember that the ongoing opening up can give the impression that the outbreak of the virus is about to go over. Unfortunately, it is not. As we gradually reduce the restrictions, it requires that we still keep control of the infection. At K2, we must continue with the simple measures that we know is working and have few negative consequences: be careful about hand washing and cough hygiene, keep at least one meter distance, and stay home when you are sick.

Enjoy the (hopefully corona-free) weekend!

 

Working environment survey: How are you?

Dear Colleague,

Working from home can be challenging and we wonder how you are doing. We have therefore prepared a simple survey to get some insight into ​​how you feel and what your work situation is like. The survey is anonymous and therefore we will not be able to have any individual follow-up based on the information in the form. If you need follow-up, I urge you to contact your nearest manager, safety representative or corporate health service.

Thank you for taking the time to give your input. Deadline 14th May.

English form: https://skjemaker.app.uib.no/view.php?id=8414760

CCBIO courses as online events: CCBIO904 Biomarkers and Tumor Biology in Clinical Practice May 25-27, and CCBIO908 Scientific Writing June 8-11

Dear all

We are happy to announce that the two courses formerly postponed due to the corona measures, now will take place as web-based courses which you can attend from your home office:

  • CCBIO904 Biomarkers and Tumor Biology in Clinical Practice: May 25-27, 2020 (full days)
  • CCBIO908 Scientific Writing & Communication Seminar, June 8-11, 2020 (4 half days)

Continue reading

Norwegian: Utlysning av forskningsmidler fra Gades Legat

Gades Legat lyser ut midler til anvendelse i forskning innen patologi, mikrobiologi og immunologi. Alle som er faglig tilknyttet forskningsmiljø ved UiB eller Haukeland Universitetssykehus innen patologi, immunologi eller mikrobiologi kan søke om midler. Søknad skal være kortfattet og inneholde:

  • Navn på søker og arbeidssted
  • Navn og kort beskrivelse av prosjektet det søkes om midler til
  • Budsjett
  • Søknad skal totalt ikke overskride 2 sider

Legatet har i senere år tildelt beløp i størrelsesorden 20-100 000 kr, men større tildelinger kan vurderes. Støtte til reiser der man ikke formidler/presenterer egen forskning vil ikke bli prioritert.

Søknadsfrist er torsdag 20. august 2020

Søknad sendes som én PDF-fil til Gades Legat ved sekretær Håvard Hoel Aass, Havard.Aass@uib.no

Norwegian: Invitasjon til nye skisser for tverrfaglege marine stipendiatstillingar 2020 – forlenget frist

Universitetet i Bergen (UiB) skal også i år lyse ut to stipendiatstillingar som eit ledd i UiB sin marine satsing. Vi ynskjer innspel frå fagmiljøa til mogelege fagområda for stillingane. Stillingane skal ikkje vere knytt til MatNat.-fakultetet, men MatNat. kan inngå i tverrfakultært samarbeid. Vi vil gjerne oppfordre til samarbeidsprosjekt der fagmiljø ved to fakultet går saman om forslaget. For meir informasjon, sjå: MaringUtvalg – Phd-utlysninger 2020 – ny frist

The Olav Thon Foundation – support for Nordic research projects in medicine 2021

The Olav Thon Foundation will allocate NOK 20 million for grants to Nordic research collaboration in the field of medicine for 2021. Applications will be assessed in light of their academic quality and the projects’ potential for development of new and groundbreaking knowledge in medicine. For 2021, the Board of the Foundation has decided to invite applications for research on reparative medicine targeting diseases in the musculoskeletal and peripheral and central nervous system.

Projects should be based on the use of stem cell biology, genetic approaches, tissue engineering, biotechnology, or regenerative medicine with the aim of repairing, regrowing or replacing damaged or diseased cells or tissues.

Research support for each project is restricted to a maximum of NOK 2.5 million per year for a maximum of four years.

You can find the announcement here.

New publications

Here are recent publications with contributions from K2 based on last week’s search on PubMed (and optionally articles that have not been included in previous lists). This time the list includes in total 8 recent publications. The entries appear in the order they were received from NCBI. If you have publications that are not included in this or previous lists, please send the references to Oda Barth Vedøy.

Continue reading

Dear all!

Now it has been nearly 7 weeks since UiB was closed due to the SARS-CoV-2 pandemic. Most of us are still obliged to use home-office. Since Monday 27/4, some more people have been allowed back in the labs. However, it is still an exception that you get access!

Remember that it is the research group leader who has to send a list of who should have access to me (including risk assessment and confirmation of passed infection control course), and then Pål as head of department decides who gets access. And then of course, there are the infection control and hygiene rules when you are at work, so it takes some organization to avoid too many people at the same time in smaller rooms. A big thank you to all those who help make it work in these times!

I would also like to remind PhD fellows who have been delayed in their progress because of home-office during the Corona period to make a written description of the delay and let the supervisor confirm this. The documentation has to be sent to the faculty administration by e-mail:  hrmed@uib.no, mark with Korona in the subject line. This documentation will be entered into the personnel folder of the individual and may form the basis for an extension of the appointment period if necessary.

Finally, I wish you all a nice International Worker’s day and a good weekend!